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Abstract  
Introduction: Athletes have higher bone mineral density (BMD) relative to non-athletes. In amenorrheic 
athletes BMD may be compromised by estrogen deficiency but it is unknown whether this is accompanied by 
structural differences.  Purpose: To compare femoral neck bone geometry and density of a/oligomenorrheic 
athletes (AA), eumenorrheic (EA) athletes and eumenorrheic controls (EC). Methods: 158 women (70 
endurance athletes and 88 controls) were recruited. Femoral neck BMD, section modulus (Z) and width were 
measured using dual x-ray absorptiometry (DXA). Menstrual function was assessed by questionnaire and 
classified as eumenorrheic (> 10 periods/year) or a/oligomenorrheic (< 9 periods/year). Results: 24 athletes 
were AA and 44 EA. Femoral neck BMD was significantly higher in EA than AA (8% difference), and EC 
(11%, difference) [mean (SE) 1.118 (0.015); 1.023 (0.020) and 0.999 (0.014) g cm-2 respectively; p<0.001]. Z 
was significantly higher in EA than EC (11% difference), [EA: 667 (19), AA: 625 (21), and EC: 592 (10) cm3 
p<0.001]. Femoral neck width did not differ between groups. All differences persisted after adjustment for 
height, age and body mass. Conclusion: The higher femoral neck Z and BMD in athletes, despite similar width, 
may indicate that exercise related bone gains are endosteal rather than periosteal   Athletes with amenorrhea had 
smaller increments in bone mass rather than structural adaptation. The maintained femoral neck width in 
controls may be an adaptive mechanism to conserve bone strength in bending despite inactivity related bone 
decrement.  
Keywords: Bone Geometry, Bone mineral Density, Menstrual dysfunction, Female, Endurance athletes  
Mini Abstract 
Low bone density (BMD) in estrogen deficient athletes may be accompanied by structural adaptations. 
Eumenorrhoeic athletes had greater BMD and section-modulus than sedentary controls, with amenorrheic 
athletes having intermediate values. All groups had similar femoral neck width, which may be an adaptive 
mechanism to conserve bone strength.  
Introduction 
Athletes have higher bone mineral density (BMD) than controls, but amenorrheic athletes have substantially 
lower BMD at the lumbar spine and femoral neck than their regularly menstruating peers (1-5). Estrogen 
deficiency in amenorrheic athletes may promote low bone mass (6), although the effect of estrogen deficiency 
on bone strength is unknown.  
 BMD has been used as a proxy for bone strength (7, 8). However bone strength encompasses the bone’s 
architecture, geometry, cortical porosity, and tissue mineralization which cannot be individually identified in 
BMD measurements (9), although some of these factors may contribute to BMD. Therefore it is important to 
consider structural determinants of bone strength such as section modulus (Z), a measure of strength in bending. 
This can be calculated using bone densitometry in the form of hip structural analysis (HSA). 
Exercise may affect structural parameters and have BMD independent influences on bone strength (10). 
Estrogen deficiency also seems to influence bone structure, based on the studies in animals and observations in 
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postmenopausal women (11, 12). Exercise has previously been shown to enhance the bone’s accrual on the 
periosteal (outer) bone surface, thus conferring greater resistance to bending, whereas estrogen may inhibit 
periosteal apposition (12). In eumenorrheic women, exercise may be a potential preventive measure for 
osteoporotic fractures, as the increased high impact loads can lead to increases in BMD relative to sedentary 
women (13, 14). However in amenorrheic athletes, estrogen deficiency is related to bone loss, raising concerns 
about increased risk of future osteoporosis (11, 12).  The effect of estrogen deficiency on bone strength will, 
however, depend on the location of bone loss. It is possible that in amenorrheic athletes, the low BMD is 
accompanied by structural differences such as increased bone diameter and that would preserve Z and strength 
in bending (11). Conversely, if the BMD decrement is from periosteal surface, Z may be reduced to a greater 
extent than BMD. The effect of amenorrhea on bone strength thus depends upon the location of the bone 
decrement, and this is currently unknown. 
Whilst it is accepted that exercise and estrogen are beneficial to bone density (12, 15) the effects of estrogen 
deficiency on bone structural parameters are in athletes are unknown. It is possible that differences in bone 
strength between amenorrheic and eumenorrheic athletes are different from those that would be predicted based 
upon BMD alone.  Thus the aim of this study was to compare bone geometry and density of a/oligomenorrheic 
athletes, eumenorrheic athletes and eumenorrheic controls.  
Methods 
Study design 
A cross-sectional design was used to compare bone status in female endurance athletes and sedentary controls 
according to menstrual function. BMD, bone mineral content (BMC), and body composition were assessed 
using dual X-ray absorptiometry (DXA). DXA was also used to estimate bone geometric parameters using the 
advanced hip structural analysis (AHA) software. Questionnaires were completed to assess current and past 
menstrual function. Bone parameters were compared between eumenorrheic controls with no history of 
menstrual dysfunction (EC) and athletes classified according to current menstrual function as eumenorrheic 
athletes (EA) or a/oligomenorrheic athletes (AA). To allow a comparison based upon cumulative exposure to 
estrogen deficiency, athletes were also classified according to menstrual history as regularly menstruating 
(RMA) or irregularly menstruating (IMA). Ethical approval was received from the National Research Ethics 
Service (NRES) and Loughborough University Ethics Committee. All participants gave written consent.   
Subjects 
68 female endurance athletes (57 runners and 11 triathletes) and 88 healthy sedentary controls aged between 18-
45 years were recruited. Athletes were recruited from sporting federations and registered running and triathlon 
clubs within the United Kingdom. They were required to be competing at an elite level for their age and/or 
training at a high volume (8-10 hours per week for a runner and 15-20 hours per week for a triathlete) in events 
from 800m to the marathon or triathlon. Athletes were excluded if they had any injury that affected their training 
in the previous 12 months. Athletes and controls were excluded if they had been pregnant or lactating in the past 
12 months; if they had commenced, ceased or changed hormonal contraception use within the previous 12 
months or if they had any medical conditions or were taking medications which were likely to affect bone 
metabolism. The 88 controls were recruited within the Loughborough community for a previous intervention 
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study, the aim of which was to determine the optimum weekly frequency of exercise to increase bone mass in 
premenopausal women who do not regularly participate in physical activity (16). Baseline measurements are 
reported here. Controls were screened to exclude individuals who had a body mass index > 30 kg/m2, 
participated in high impact or weight bearing exercise more than 1 h/week, or were not regularly menstruating 
(< 10-13 menstrual cycles per year) (16). 
BMD and geometry 
DXA was used to measure BMD and BMC of the lumbar spine (L1-L4), and femoral neck. Bone geometric 
properties of the femoral neck were estimated using the AHA software (Lunar Prodigy, GE Healthcare, 
Madison, WI, U.S.A version encore 12.2) to determine cross-sectional area (CSA), Z, minimal neck width and 
strength index. Femoral strength index is the ratio of estimated compressive yield strength of the femoral neck 
to the expected compressive stress of a fall on the greater trochanter adjusted for the patient’s age, height and 
weight. This is estimated from Z but incorporates other variables also (17,18)  
Menstrual function 
Questionnaires were used to assess current and past menstrual function and hormonal contraceptive use.  
Participants were classified into three groups: a/oligomenorrheic phenotype athletes (AA) (< 9 periods per year), 
eumenorrheic athletes (including those taking hormonal contraception) (EA) (> 10 periods per year), and 
eumenorrheic controls (EC). Participants who reported changes in hormonal contraception use in the previous 
12 months were excluded from the study.  
Fasted serum samples (not synchronised to menstrual cycle) were collected. A high prevalence of polycystic 
ovary syndrome (PCOS) has been reported in female athletes (19,20) serum samples were analysed for anti-
mullerian hormone (AMH) to  differentiate hypothalamic amenorrhoea from PCOS and premature ovarian 
failure: AMH is elevated in PCOS bot does not vary over the menstrual cycle (21). Analysis was conducted 
using generation II ELISA kit (Beckman Coulter, High Wycombe, UK)). Any athlete identified as having 
elevated AMH values (> 67.1 pmol/L) was excluded from this study.  
Calculation of menstrual index in athletes 
Menstrual index was calculated using a the equation derived by Grimston et al (17), to provide a summary 
measure of menstrual history in female athletes, which may involve changes in menstrual function (amenorrhea, 
oligomenorrhea and amenorrhea) over a life span. Athletes were asked to record their age at menarche (M), the 
number of years they had been amenorrheic (0 – 3 periods per year) and oligomenorrheic (4 – 10 periods per 
year) since menarche. Using the equation below menstrual index (MI) was calculated: 
MI = 11.5 (no. yrs) + 7 (no. yrs) + 1.5 (no. yrs) 
                 C – M 
MI represents the average menses per year over the entire length of menstruation, 11.5, 7 and 1.5 represent the 
annual menstrual frequency at midpoints of the menstrual categories eumenorrhea, oligomenorrhea and 
amenorrhoea respectively, M represents age at menarche, and C is the current age.   
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Based on the MI categories derived by Grimston et al (22), athletes were categorized into two groups, athletes 
with a history of menstrual regularity MI > 10 (RMA) and athletes with a history of menstrual irregularity MI < 
10 (IMA).  
Anthropometric measures 
Height and body mass were assessed using standard protocols using a stadiometer and a beam balance scale 
respectively in all participants.  Body composition in athletes was assessed using DXA.  
Statistical analysis 
Descriptive statistics (mean and standard errors) were used to characterize the sample. Analysis of variance 
(ANOVA) was used to compare means between menstrual function groups, with a Tukey’s HSD Post Hoc test 
determining which groups differed. An analysis of covariance (ANCOVA) was used to adjust for age, height, 
and body mass. All statistical analysis was carried out using SPSS 16.0 (SPSS Chicago Illinois, USA). The level 
of significance was set at p value <0.05. 
Results 
The physical characteristics of the three groups can be found in table 1. Of the sixty-eight endurance athletes 
forty-four (65%) were eumenorrheic and 24 (35%) were currently a/oligomenorrheic (< 9 periods per year). 
None of the AA athletes had elevated anti-mullerian hormone values which are indicative of PCOS (median 
(IQR) 20.7 (19.2) pmol/L). The total duration of reported amenorrhoea in the a/oligomenorrheic group was 
(mean (SD) 4.5 (4.9) years. Nineteen (43%) of the eumenorrheic athletes were currently taking hormonal 
contraception. According to the MI, 26 (40%) athletes, but none of the controls, had a history of irregular 
menstruation. Three athletes did not provide adequate information to determine menstrual history using the MI.  
EC had significantly lower height, and greater age and weight than both athlete groups, whether athletes were 
classified according to either current menstrual function or menstrual history (Table 1). Physical characteristics 
of athletes did not differ significantly according to either menstrual function or menstrual history (Table 1). 
Controls had greater percent body fat (29.2 (6.4)%) compared to both athlete groups. In the athletes, percent 
body fat did not differ significantly between eumenorrheic and amenorrheic athletes: mean (SD) being 17.7 
(5.9) and 16.1 (5.4) % respectively.  
Bone mineral density (BMD) and bone mineral content (BMC) 
Comparisons of BMD and BMC according to current menstrual function are shown in table 2. BMD of the 
femoral neck was significantly higher in EA than both AA and EC (by 8% and 11% respectively, p<0.001). 
Femoral neck BMC was also significantly higher (12%, p<0.001) in EA than the EC s, although AA did not 
differ significantly from other groups (figure 1).  
Lumbar spine BMD was 8% higher in the EC than the AA (p=0.005). There were no significant differences 
between the two athlete groups (mean (SE) AA: 1.092 (0.026), EA: 1.148 (0.020) ,p=0.369). 
Bone geometry 
Bone geometric properties estimated at the hip using DXA are summarised in table 2. Femoral neck CSA was 
significantly higher in EA compared to AA and EC (9% and 11% difference respectively, p<0.001), similarly to 
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the femoral neck BMD. Z was significantly higher in EA than EC (11% difference, p=0.001). The strength 
index of the bone was significantly higher in EA and AA than EC (23% and 14% differences respectively, 
p<0.001) (figure 1). 
There were no significant differences in geometric properties (Z, strength index and minimal neck width) 
between AA and EA groups (% differences, Z: 6%, p=0.272, strength index: 9%, p=0.128 and minimal neck 
width: 2% p=0.655).  
BMD and bone geometry according to menstrual index (MI) 
To examine whether bone properties differed according to estrogen exposure across the reproductive period 
sixty-five of the athletes were re-grouped according to menstrual index. Three of the athletes were excluded 
from the analysis as they provided incomplete information. Results were generally similar to those from the 
current menstrual function analysis at the lumbar spine; with those athletes reporting a history of IMA (N=26, 
MI<10) having significantly lower lumbar spine (L1-L4) BMD than RMA athletes (9% difference, p=0.007) 
and EC groups (11% difference, p<0.001). In contrast to the findings according to current menstrual function, 
lumbar spine (L1-L4) BMC was significantly lower in IMA than RMA athletes (6% difference, p=0.026).  
IMA athletes had significantly higher CSA (6% difference, p=0.045) and strength index (20% difference, p< 
0.001) than EC group. Similarly RMA athletes had significantly higher femoral neck BMD (10% difference, p 
<0.001), CSA (9% difference, , p <0.001),  Z (11% difference,  p=0.002) and strength index (16% difference, 
p<0.001) than EC, but in contrast to the findings according to current menstrual function femoral neck BMD 
and CSA did not differ significantly between the athlete groups (Table 2). 
Adjustments for differences in physical characteristics 
After adjustment for age, body mass and height, similar significant differences in BMD, BMC and bone 
geometric properties at the femoral neck according to current menstrual function persisted. When comparing 
groups according to menstrual history athlete groups now showed significantly higher BMD after adjustments 
for physical characteristics (IMA: 1.077 (0.24), RMA: 1.134 (0.019), EC: 0.985 (0.013) g cm-2, p<0.05), BMC 
(IMA: 5.0 (0.1), RMA: 5.2 (0.1), EC: 4.8 (0.1) g, p<0.05) and CSA (IMA: 157 (4), RMA: 162 (3), EC: 150(4) 
mm2, p <0.05) at the femoral neck than EC. At the lumbar spine, differences in BMD according to current 
menstrual function were no longer significant but RMA athletes still had a significantly higher BMD at the 
lumbar spine compared to IMA athletes.  
Discussion 
This study is novel in that it compares bone geometry according to menstrual function in female endurance 
athletes and sedentary controls. A/oligomenorrheic athletes had lower BMD compared to eumenorrheic athletes 
but this was still higher than the eumenorrheic controls. Section modulus showed similar magnitude of 
differences between groups to BMD. Femoral neck width was similar in all groups, suggesting that the higher 
BMD and BMC in athletes is related to additional endosteal or trabecular bone, rather than periosteal apposition. 
Menstrual dysfunction was prevalent in this sample of athletes with twenty four (35%) of the athletes reporting 
current menstrual dysfunction and 40% reporting a history of menstrual dysfunction when calculated as MI. 
These findings are consistent with previous reports which have indicated menstrual dysfunction is present in 
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between 1 and 44% (23) of athletes depending on the sport population surveyed and the definition of menstrual 
dysfunction (23,24). Contrary to some previous findings (25), there were no significant differences in height, 
body mass and age between the a/oligomenorrheic, and eumenorrheic athletes, although the sedentary control 
group were significantly older, heavier and shorter than the athlete groups.  
Athletes had a significantly higher femoral neck BMD than the eumenorrheic sedentary controls in accordance 
with earlier studies (11, 13, 14, 23, 26). Torstveit and Sundgot-Borgen (26) found low BMD was three times 
more likely in non-athletes than in athletes, with athletes having 3-20% higher BMD compared to non-athlete 
controls. In the present study eumenorrheic athletes had approximately 14% higher BMD than controls after 
adjustments for age, height and weight. A/oligomenorrheic athletes had intermediate values; with mean BMD 
8% lower than that in eumenorrheic athletes but 2% higher than that in controls. Prolonged exercise may thus 
partly counteract the skeletal effects of prolonged estrogen deficiency (11, 12, 24). Similarly gymnasts who 
engage in a higher impact activity have greater BMD than normally active individuals despite later menarche 
and periods of amenorrhoea (24, 27). 
The differences in BMD observed here may not entirely represent the differences in bone strength between 
groups, as exercise and estrogen deficiency may have structural effects that influence bone strength 
independently of BMD. This study is the first to examine the effects of amenorrhea on hip geometric parameters 
such as section modulus, related to strength in bending. Eumenorrheic athletes had significantly greater section 
modulus compared with eumenorrheic controls, which persisted after adjustment for weight, height and age. The 
decrement in section modulus in amenorrheiccompared to eumenorrheic athletes was of similar magnitude as 
that for femoral neck BMD (6% vs 8%) but was not statistically significant (p=0.272). As with BMD, Z was not 
lower in amenorrheic athletes compared to regularly menstruating controls. A previous study in anorexic women 
with secondary amenorrhoea found that low BMD relative to controls was accompanied by lower structural 
properties (Z, cortical thickness), hence the bone’s resistance to bending was compromised at the hip compared 
to healthy controls (28). The amenorrheic athletes in this study had a greater duration of amenorrhea than the 
anorexic women in the study of di Vasta et al (28), so the differences in BMD seem likely to be due to 
differences in skeletal loading, lean mass and possibly other nutritional or endocrine deficiencies that may be 
associated with anorexia. 
There were no significant differences in femoral neck width between any of the groups although both exercise 
(11) and estrogen deficiency (29) have been suggested to enhance periosteal expansion. Exercise has been 
reported to increase bone diameters at the tibia and radius (30,31), but bone width at the femoral neck did not 
differ between athletes engaging in different types of sports and controls (32). The discrepancy between studies 
may be explained by differences in loading between these skeletal sites, with more torsional loading at the tibia 
and radius. Previous findings in estrogen deficient women have been consistent with estrogen deficiency 
promoting periosteal expansion. In adolescents with anorexia, bone outer diameter was maintained despite a 
substantial decrement in bone density and cross-sectional area relative to controls (28). In postmenopausal 
women, periosteal diameter increased most rapidly in those with highest sex hormone binding globulin (hence 
presumably lower bio-available estradiol (33). However, differences were only 0.03 mm/year so it is possible 
that duration of amenorrhoea and/or exercise in this study were not great enough to have yielded detectable 
differences in the femoral neck width.  
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To have higher BMC and BMD at the femoral neck with the same bone width implies differences are related to 
either endocortical or trabecular bone. The fact that Z is higher in the athletes may make endocortical 
increments seem more likely. However, the study is cross-sectional so may be affected by selection bias. For 
runners, lightness offers a competitive advantage, so women with smaller skeletal size and mass may be more 
likely to succeed. It is possible that if athletes had not exercised, they would have had a smaller neck width than 
the controls consistent with lower body mass. It is therefore possible to suggest that exercise-associated 
periosteal apposition has counteracted an otherwise smaller neck width in athletes.  
Although femoral neck BMD was significantly higher in athletes, lumbar spine BMD was highest in the 
sedentary controls, although differences were not significantly significant after adjustments for age, height and 
weight. Athletes with a history of amenorrhea had significantly lower spine BMD than their regularly 
menstruating peers, although there were no significant differences according to current menstrual function. 
Previous studies have reported lower lumbar spine BMD in amenorrheic than eumenorrheic athletes (13, 34-36). 
The lumbar spine may be more responsive to hormonal stimuli than the femoral neck due to the higher ratio of 
trabecular (62-70%) to cortical bone (30-38%) (23) and so theoretically may be more susceptible to estrogen 
deficiency related bone loss. That lumbar spine BMD differed according to menstrual index rather than current, 
amenorrhea, may suggest that cumulative estrogen exposure is most important. Another possible explanation is 
that many of the currently a/oligomenorrheic athletes in this study took part in resistance training, which may 
compensate for potential estrogen deficiency related losses in BMD at the lumbar spine by increased loading 
(26) and so may explain the preservation of the lumbar spine BMD in currently amenorrheic athletes in this 
study.  
The limitations of this study include that bone geometric properties were estimated at the hip using AHA which 
only provides a 2-dimensional image in one plane. Differences in positioning of the femoral neck could result in 
changes in the measure of the geometric properties of the hip. In order to achieve a more accurate measure of 
bone geometry a 3-dimensional image would be preferable such as given by CT or pQCT. However in a sample 
of women of reproductive age there may be ethical concerns about the radiation dose required for hip CT 
measurement. Menstrual status was assessed retrospectively. Whilst amenorrhea is indicative of estrogen 
deficiency, we did not assess serum or urinary metabolites of estrogen throughout the menstrual cycle (24) 
which would have been demanding for participants and was beyond the scope of this investigation. The control 
group was not matched for age, height, and body mass to the athlete groups which would have been the optimal 
study design, as matching for body mass may offset the effects of exercise. However physical characteristics 
were added as covariates and findings were not substantially affected so the different characteristics probably 
did not contribute to findings.  
The findings from this study may have implications for the clinical and applied sports medicine field illustrating 
that the skeletal effects of estrogen deficiency in amenorrheic athletes may be counteracted by loading induced 
bone gains. Even though these findings may indicate that amenorrheic athletes who participate in loading sports 
have some preservation of bone mineral density we cannot be sure that this adaptation is adequate to withstand 
the potentially higher levels of loading in this group.  It is clear that the bone adaptations seen in eumenorrheic 
athletes are not as pronounced in a/oligomeonorrheic athletes therefore potentially conferring greater risk of 
bone dysfunction. Therefore it is important to continue to address oligomenorrhoea and amenorrhoea and its 
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underlying causes in the athletic population. It can therefore be concluded from this study that eumenorrheic 
athletes had significantly higher femoral neck Z, as well as BMD, than controls. Amenorrheic athletes had 
intermediate values for both parameters, suggesting that amenorrhea limits exercise induced bone gains rather 
than inducing structural adaptation. Femoral neck width was very similar in all groups despite higher BMC in 
athletes; therefore, the additional bone in athletes may represent more endosteal bone, rather than periosteal 
apposition. The maintained femoral neck width in controls may be an adaptive mechanism to conserve bone 
strength in bending despite inactivity related bone decrement.  
Funding: No external funding supported the work outlined in the manuscript. 
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Table 1: Physical Characteristics of athletes and sedentary controls according to current menstrual 
function (mean (SD) 
  Current Menstrual Function  
 
EC 
(N=88) 
EA 
(N=44) 
AA 
(N=24) 
Age (years)  32.8 (8.4) 26.9 (7.9) * 23.9 (6.4) * 
Body Mass (kg)  61.8 (10.2) 55.4 (6.6) * 55.4 (4.9) * 
Height (m)  1.63 (0.10) 1.66  (0.10) * 1.68 (0.05) * 
BMI (kg/m2)  23.2 (3.7) 20.0 (1.3) * 19.6 (1.5)* 
Body Fat (%)   17.7 (5.9) 16.1 (5.4) 
Age at Menarche (yrs)  - 13.9 (0.2) 14.5 (0.1) 
Training (hrs/week) - 12.8 (4.7) 13.1 (4.9) 
*significantly different from EC (p<0.05 in ANOVA)  
No significant differences between EA and AA 
EC: Eumenorrheic control, EA: Eumenorrheic Athletes, AA: A/oligomenorrheic Athletes,  
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Table 2: Comparisons of BMD, BMC and geometric measures in female athletes and sedentary controls 
according to current menstrual function and menstrual Index (MI): mean (SE) 
 
Controls 
Athlete Grouped according to 
current Menstrual function 
Athlete Grouped according to 
Menstrual history  (MI) 
 
EC                 
(N=88) 
EA 
(N=44) 
AA 
(N=24) 
RMA  
(N=39) 
IMA  
(N=26) 
Bone mineral density 
(BMD)  
   
  
BMD Femoral Neck (g/cm2)  0.999 (0.014) 1.118 (0.015) a 1.023  (0.020) b 1.113 (0.014)
a 1.059 (0.022) 
BMD Spine (L1-L4) (g/cm2)  1.188  (0.014) 1.148 (0.020) 1.092 (0.026) a 1.168 (0.020) 1.069 (0.024)ac 
Bone mineral content 
(BMC)     
  
BMC Femoral Neck (g)  4.6 (0.1) 5.2 (0.1) a 4.8 ( 0.1) 5.1 (0.1) 5.0 (0.1) 
BMC Spine (L1-L4) (g)  61.4 (1.1) 62.0 (1.7) 57.7 (1.9) 61.4 (1.5) 56.3 (1.8)c 
Femoral neck geometric 
measures     
  
CSA (mm2)  144 (2) 161 (3) a 148  (4 )b 159 (3) 154 (3) a 
Minimum neck width (mm)  28.5 (0.2) 28.4 (0.3) 28.9 (0.5) 28.4 (0.4) 28.4 (0.4) 
Section modulus (Z) (mm3)  592 (10) 667 (19) a 625 (21) 665 (22) a 624 (18) 
Strength Index  1.61 (0.03) 2.06 (0.0)6 a 1.87 (0.09) a 1.94 (0.06)a 2.04 (0.10) 
 
a sig diff from EC, b sig diff from EA, c sig diff from RMA,  p<0.05 ANOVA according to Tukey’s Post Hoc 
test  
EC: Eumenorrheic control, EA: Eumenorrheic Athletes, AA: A/oligomenorrheic Athletes, RMA: Menstrual 
Index Regular Menstruating Athletes, IMA: Menstrual Index Irregular Menstruating Athlete. 
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Figure 1 Femoral neck bone parameter mean differences for eumenorrheic (EA) and amenorrheic (AA) athletes  
from controls (mean difference and 95% CI bars).  
 
